Mutation and overexpression of the P53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomasFU-SHING LIU; KOHLER, M. F; MARKS, J. R et al.Obstetrics and gynecology (New York. 1953). 1994, Vol 83, Num 1, pp 118-124, issn 0029-7844Article

High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervixJIN-CHING LIN; SHIH-CHU HO, E; JIAN-SHENG JAN et al.Gynecologic oncology (Print). 1996, Vol 61, Num 1, pp 101-108, issn 0090-8258Article

Overexpression or mutation of the p53 tumor suppressor gene does not occur in malignant ovarian germ cell tumorsFU-SHING LIU; SHIH-CHU HO, E; JUNG-TA CHEN et al.Cancer. 1995, Vol 76, Num 2, pp 291-295, issn 0008-543XArticle

Overexpression of p53 is not a feature of ovarian granulosa cell tumorsFU-SHING LIU; SHIH-CHU HO, E; CHUNG-RU LAI et al.Gynecologic oncology (Print). 1996, Vol 61, Num 1, pp 50-53, issn 0090-8258Article

Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in uteroBOYD, J; TAKAHASHI, H; WAGGONER, S. E et al.Cancer. 1996, Vol 77, Num 3, pp 507-513, issn 0008-543XConference Paper

Allelotype of endometrial carcinomaFUJINO, T; RISINGER, J. I; BERCHUCK, A et al.Cancer research (Baltimore). 1994, Vol 54, Num 16, pp 4294-4298, issn 0008-5472Article